Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy

CONTEXT: The immune checkpoint inhibitors (ICIs) nivolumab and pembrolizumab have shown dramatic efficacy with low toxicity in international studies of advanced solid cancers. No published Indian experience with ICIs exist other than isolated case reports. AIMS: The aim of this study is to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vineet Govinda, Rangaraju, Ranga Rao, Abbas, Waseem, Bajpai, Peush, Khetrapal, Ruchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
ORIGINAL ARTICLE: Immuno Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348784/
https://www.ncbi.nlm.nih.gov/pubmed/30766859
http://dx.doi.org/10.4103/sajc.sajc_167_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348784/
https://www.ncbi.nlm.nih.gov/pubmed/30766859
http://dx.doi.org/10.4103/sajc.sajc_167_18

Ejemplares similares